AbbVie Inc.
ABBV
$210.75
-$0.79-0.37%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.71% | 0.72% | -1.83% | -4.12% | -6.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.71% | 0.72% | -1.83% | -4.12% | -6.44% |
| Cost of Revenue | 0.78% | -0.44% | -3.17% | -2.77% | -3.30% |
| Gross Profit | 5.01% | 1.22% | -1.23% | -4.71% | -7.77% |
| SG&A Expenses | 4.46% | 11.34% | 6.26% | 5.46% | 5.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 30.00% | 193.89% | 193.89% | 100.00% | -900.00% |
| Total Operating Expenses | 5.42% | 7.10% | 3.29% | 2.02% | 1.92% |
| Operating Income | 0.17% | -11.15% | -11.23% | -14.95% | -20.04% |
| Income Before Tax | -40.54% | -10.07% | -32.38% | -16.55% | -53.62% |
| Income Tax Expenses | -141.39% | 39.27% | -2.39% | 6.71% | -15.63% |
| Earnings from Continuing Operations | -12.05% | -21.29% | -38.45% | -20.93% | -58.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.00% | -57.14% | -57.14% | -37.50% | -11.11% |
| Net Income | -12.03% | -21.37% | -38.53% | -20.99% | -58.91% |
| EBIT | 0.17% | -11.15% | -11.23% | -14.95% | -20.04% |
| EBITDA | -1.07% | -9.16% | -8.60% | -10.20% | -13.73% |
| EPS Basic | -12.09% | -21.38% | -38.53% | -20.80% | -59.00% |
| Normalized Basic EPS | -1.34% | -11.76% | -11.26% | -14.16% | -19.67% |
| EPS Diluted | -12.11% | -21.38% | -38.41% | -20.51% | -58.85% |
| Normalized Diluted EPS | -1.28% | -11.73% | -11.22% | -14.11% | -19.61% |
| Average Basic Shares Outstanding | -0.01% | -0.06% | -0.14% | -0.20% | -0.18% |
| Average Diluted Shares Outstanding | -0.07% | -0.11% | -0.20% | -0.27% | -0.25% |
| Dividend Per Share | 5.01% | 4.73% | 4.79% | 4.84% | 4.90% |
| Payout Ratio | 0.19% | 0.33% | 0.70% | 0.32% | 1.55% |
